Berndt Modig

Companies

• Pharvaris N.V.Board member Mar 18, 2026 to now¹
• Pharvaris N.V.Chief executive officer Mar 18, 2026 to now¹
• Sio Gene Therapies Inc.Board member Jun 10, 2015 to Apr 19, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PNPharvaris N.V. PHVS778,334 shares³$23.1M at $29.67Sep 21, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 17, 2026Exercised options 300,000 shares at $35.00 of Pharvaris N.V.³
• Sep 14, 2026Sold 2,291 shares at $39.40 of Pharvaris N.V.⁴
• Aug 14, 2026Sold 2,292 shares at $34.77 of Pharvaris N.V.⁵
• Jul 13, 2026Sold 2,292 shares at $34.97 of Pharvaris N.V.⁶
• Jun 15, 2026Sold 100 shares at $31.46 of Pharvaris N.V.⁷
• Jun 15, 2026Sold 2,191 shares at $31.05 of Pharvaris N.V.⁷
• May 18, 2026Sold 2,292 shares at $29.22 of Pharvaris N.V.⁸
• Apr 16, 2026Sold 2,292 shares at $28.60 of Pharvaris N.V.⁹
• Apr 9, 2026Sold 200 shares at $28.42 of Pharvaris N.V.¹⁰
• Apr 9, 2026Sold 23,133 shares at $27.74 of Pharvaris N.V.¹⁰